Allstate in the news

A Georgia appeals court upheld the dismissal of an uninsured motorist claim against Allstate, ruling that a judgment against the at-fault uninsured driver is required before the insurer owes benefits.

Allstate executive Jeevanjee Zulfikar converted 2,371 restricted stock units into common shares, with 4,744 units remaining for future conversion.

Allstate opened a training facility in Dallas, the Auto Lab, to improve claims adjusters' skills in assessing complex vehicle damage for various car types.

Morgan Stanley lowered its price target for Allstate stock to $240, while other analysts provided mixed ratings, and the company reported strong quarterly earnings and insider selling.

Allstate opened the Auto Lab in 2026 to train auto claims adjusters using real damaged vehicles, new technologies, and hands-on scenarios to better assess and manage claims.

Allstate will hold its Q3 2026 earnings call on November 5, 2026, following the release of financial results on November 4, 2026.

Morgan Stanley reduced its price target on Allstate to $240 from $265.

Allstate will release its third-quarter results after 4:15 p.m. on November 4th, with a follow-up call the next morning.

Senators Warren and Hawley initiated an investigation into Allstate and other major insurers over increasing claim denials amid rising underwriting profits.

The Washington Insurance Commissioner fined USAA $140,000 and Allstate $90,000 for various claims handling violations and other unfair practices.

Allstate will release its Q3 2026 results on November 4, following a strong Q2 that surpassed analyst estimates, amidst diverging analyst price targets and recent cautious adjustments.

Senators Elizabeth Warren and Josh Hawley are probing major insurers like Allstate over a rise in claims that result in no payouts, questioning industry practices and compensation structures.

Allstate offers a Playoff Predictor tool that allows users to select a contender, make season picks, and see predictions for how the season will play out.

Allstate's stock target was cut by Citi despite strong Q2 results, citing lower book value estimates, a higher discount rate, and competitive risks.

Allstate declared $29.3 million in preferred dividends, payable October 15, 2026, for Series H, I, and J preferred stock, while its stock remained at EUR 198.85.

Allstate sued three New York pharmacies for alleged no-fault insurance fraud involving expensive and medically unnecessary prescription pain treatments.

Allstate's stock saw a slight after-hours dip, while the company declared preferred dividends and reported substantial catastrophe losses for July and August.

Allstate Insurance is refusing to pay for roof repairs for an Idaho homeowner after a storm, while neighbors with different insurers had their claims covered.

Goldman Sachs adjusted Allstate's price target to $250 from $280 while maintaining a Neutral rating.

Allstate is suing three New York pharmacies for allegedly overbilling for pain cream through illegal kickback schemes.